Scientists use AI to find stable forms of molecules for drug discovery
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Oct-2026 21:17 ET (22-Oct-2026 01:17 GMT/UTC)
New York University researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where their hydrogen atoms should be positioned.
Their research, published in the journal Chemical Science, addresses a longstanding challenge in molecular design and drug discovery: how to rapidly and reliably determine the stable form of molecules that share a molecular formula but readily convert into different forms.
Trial shows benznidazole taken once a day for 30 days, half the standard daily dose, is as effective as the 60-day treatment, causing fewer side effects
A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days. The TESEO trial, co-led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the “la Caixa” Foundation, the University of Texas at El Paso (UTEP, USA), and CEADES (Bolivia), reports these results in The Lancet Infectious Diseases.
Virginia Tech researchers found that mice hearing a sound associated with danger moved closer to familiar companions, but not strangers. The study identifies oxytocin signaling and a brain connection between the amygdala and hippocampus as essential to this response, offering insight into how learned threats drive animals to seek safety.